Professor Frank Joseph

Consultant Physician in Endocrinology, Clinical Director for Urgent Care

Prof. Joseph is a Consultant Physician in Endocrinology, Diabetes, General & Acute Internal Medicine at the Countess of Chester Hospital. He is the clinical lead for an award winning Integrated Diabetes Services. He is Chairman of the North West pre-gestational diabetes audit group and Chairman of the Western Cheshire Diabetes Network.

His other leadership role includes Clinical Director for Urgent Care. He has also previously been the chairman of the new consultant committee, chairman of the Acute Medical Care Committee and the Acute Care Fellow at the Royal College of Physicians, London. He is currently the Future Hospital Officer at the Royal College of Physicians, London and is a member of the Future Hospital Program Board.





Prof. Joseph is very much a family man with 3 young children, Holly, Megan and Aiden and his specialist subject courtesy of his youngest is Thomas the Tank Engine!

He enjoys playing the guitar and has spent some time as a thespian doing Shakespeare amongst other things. He also enjoys sport and believes that healthy is the new happy!


Professor Joseph taught on Undergraduate and Postgraduate medical curricula with regard to diabetes, endocrinology and clinical leadership. He has also taught in multi-professional settings on diabetes and endocrine diagnosis and therapies. In his role at the Royal College of Physicians he contributes to the development and direction of medical education and training.



  • Society for Endocrinology, Undergraduate Achievement Award 2013 – for encouraging excellence in the study of endocrinology by undergraduate students.
  • Member of steering group, developing content and delivering RCP, London's "Doctors as Leaders" course
  • Convener, 1st ever Soc. for Endo Clinical Cases Day, Liverpool 2011 with conference grant of £3000
  • Administrator & Co-organiser MRCP PACES exam hosted by COCH 2009-2011. Examiner feedback “superbly organised”
  • Organising quarterly CPD sessions for Mersey New Consultants Forum
  • Co-organising Mersey RCP Teach-ins and regional updates at the LMI as part of the Mersey RCP team
  • Successful obtainment & regular delivery of diabetes education sessions on monthly mid-wife training days
  • Authored NHS Clinical Knowledge Summaries for Type 2 Diabetes and Insulin treatment
  • Author of topics on the Endo.Soc. public website,“You and Your Hormones" - received certificate of recognition for patient education from the Endoc. Soc.
  • Lead for Mersey Diab & Endo Regional SpR evening teaching programme
  • Delivering lectures for Local Branch of Diabetes UK patient group
  • Lecturer on Pastest MRCP part 1course (3 times a year)
  • Convenor, Lecturer and Chair of Chester & North Wales Endocrine Meeting 2012
  • Invited lectures:
  • Metab. Bone Dis. Conf., Lon. 2012
  • British Assoc. of Cardiovasc Prevention & Rehab. Conf. Birm. 2012
  • Regional obstetric & rheumatology SpR teaching
  • Liverpool Univ Careers Day 2012
  • Young Diabetologists Forum & Endo. Soc. Careers Fayre 2012
  • Administrator and organiser MRCP PACES exam 2008-2010 and assisted with organisation 2011
  • Associate Royal College of Physicians tutor 2002-3.
  • Organising committee for MRCP PACES Roadshow at Countess of Chester 2010.
  • Lecturer on Pastest MRCP part 1 written course (3 times a year).
  • Clinical Supervisor for Advanced Nurse Practitioners undertaking Independent  Prescribing Courses
  • Educational Lead for Diabetes in pregnancy.
  • Set up and chaired “Mersey Joint Diabetes and Renal SpR Meetings and Educational Grant Program” 2008-2009
  • Lecturer on the John Moore’s University Pharmacy Diploma course Diabetes and Endocrinology Module 2007-2008
  •  Patron of Local Branch of Diabetes UK - attending patient meetings & delivering lectures.
  • Advanced Life Support instructor (2 per year)
  • Organisation of departmental diabetes dept monthly education programme
  • Undergraduate teaching, diabetes and endocrine tutorials for juniors (including surgical & A+E juniors), F1 tutorials, MRCP tutorials & PACES teaching
  • Full participation and lectures delivered in hospital’s grand rounds & rolling half days.
  • Frequently invited to deliver lectures to GPs, practice nurses & pharmacists.
  • Excellent feedback scores always received for teaching


He leads a successful clinical trials unit that has achieved highest recruitment figures nationally to studies involving cutting edge therapies for diabetes and its complications. He publishes in peer reviewed journals on a regular basis on various diabetes and endocrine topics and presents nationally and internationally.

The areas of focus of academic work include the use of multimedia education in people with diabetes and the impact of education on knowledge, anxiety and clinical outcomes in different groups of people with diabetes.

Published work


  • CME in Acute Medicine; Clinical Medicine; July 2015
  • Acute Care Toolkits; Royal College of Physicians, London



N Malipatil, F Joseph : Chapter 1: Introduction: Terminology, Etiologic classification of diabetes, Epidemiology, Diagnosis and Screening for diabetes mellitus. Managing Diabetes. Ed. J Vora & M Evans; Published by Springer Healthcare Ltd. 2012

F Joseph, A Mon, JP Vora. Chapter: Managing the normotensive type 2 diabetic patient with microalbuminuria. Clinical Challenges in Diabetes. Ed. AH Barnett. Oxford Publications. 2010



Maria Woolley, Colin Jones, Joanne Davies, Usha Rao, David Ewins, Sunil Nair, Frank Joseph. Type 1 diabetes and pregnancy: a phenomenological study of women’s first experiences. Practical Diabetes Vol. 31 (1) 2015 January/February

Khan M, Joseph F. Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica. 2014;2014:328592. doi: 10.1155/2014/328592. Epub 2014 Sep 17. Review

Steve Chaplin, Claire McCourt, Frank Joseph   Xigduo: dapagliflozin plus metformin for T2DM. Prescriber Volume 25 Issue 19 (5 October 2014) (p 36-38)

Deepa Beeharry, Franklin Joseph, David Ewins & Sunil Nair  Dietary Management of Diabetic Chronic Kidney Disease: Current Nutrition Reports September 2014, Volume 3 :10.1007/s13668-014-0093-3

Joseph F. ‘Just do it, ’cos I’ve got your back!’ Diabetes care: the West Cheshire Way. Practical Diabetes 2014; 31(4): 169–172

Buckley JP, Mellor DD, Morris M, Joseph F. Standing-based office work shows encouraging signs of attenuating post-prandial glycaemic excursion.

Occup Environ Med. 2014 Feb;71(2):109-11. Epub 2013 Dec 2.

BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013 Dec 26;369(26):2492-503. Epub 2013 Nov 9.

UK Dopamine Agonist Valvulopathy Group. A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists. J Clin Endocrinol Metab. 2014 Jan;99(1):90-6. Epub 2013 Dec 20.

UK Acromegaly Register Study Group (UKAR-3).Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf). 2013 Nov;79(5):689-99. Epub 2013 Apr 24.

Joseph F. Editorial: Change is the only constant: How do we make the best therapeutic decisions in the face of ever-evolving diabetes care? Supplement to Diabetes Digest Volume 12 Number 4 2013

Steve Chaplin, Frank Joseph Lixisenatide (Lyxumia): new GLP‐1 mimetic for type 2 diabetes Prescriber Volume 25 Issue 6 (19 March 2014) (p 14-16)

Steve Chaplin, Frank Joseph Insulin degludec (Tresiba): new ultra long‐acting basal insulin. Prescriber Volume 24 Issue 17 (5 September 2013) (p 13-18)

Bennett K, Joseph F. Diabetes requiring insulin – recent developments in management. Prescriber. Volume 24 Issue 11 (5 June 2013) (p 21-29)

Joseph F. Treating to target: Comparing analogue and human basal insulins. Supplement to Diabetes Digest Vol 12 No 2 2013

R Seys Llewellyn, F Joseph, D Ewins, N Goenka, E Domanne, A Franks. BMJ 2012;344:e2122 (Published 21 March 2012)

Gardner CJ, Irwin AJ, Daousi C, McFarlane IA,  Joseph F , Bell JD, Thomas EL, Adams VL, Kemp GJ, Cuthbertson DJ. Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study. Eur J Endocrinol. 2012 Jun;166(6):993-1002. Epub 2012 Mar 20

Sharma D, Morrison G, Joseph F, Purewal TS, Weston PJ. The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis. Diabetologia. 2011 Nov;54(11):2768-70. Epub 2011 Aug 14.

Jones R, Jones J, Causer J, Ewins D, Goenka N, Joseph F. Yew tree poisoning: a near-fatal lesson from history. Clin Med. 2011 Apr;11(2):173-5.

Joseph F, Reeve-Fowkes A, Ewins D, Goenka N. Medicine at the sharp end. Clin Med. 2009 Dec;9(6):630-1

S Nair, F Joseph, D Ewins, J Wilding and N Goenka. From history to reality: sodium glucose co-transporter 2 inhibitors – a novel therapy for type 2 diabetes mellitus. Practical Diabetes International. 2010 Sept;27(7):311-316

K Perkins, S Edwards, F Joseph, D Ewins and N Goenka. Impact of a Diabetes Inpatient Specialist Nurse on hypoglycaemia-related hospital admissions. Journal of Diabetes Nursing. 2010 Aug;14(7):271-277

Joseph F, Anderson L, Goenka N, Vora J. Starvation-induced True Euglycemic Diabetic Ketoacidosis in Severe Depression. Journal of General Internal Medicine. 2009 Jan;24(1):129-31

Anderson L, Joseph F, Goenka N, Patel V. Isolated thyroxine malabsorption treated with intramuscular thyroxine injections. American Journal of Medical Sciences. 2009 Feb;337(2):150-2

Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.  Effects of Growth Hormone Administration on Bone Mineral Metabolism, Parathyroid Hormone Sensitivity and Parathyroid Hormone Secretory Rhythm in Postmenopausal Women with Established Osteoporosis. Journal of Bone and Mineral Research. 2008 May;23(5):721-9.

Kandaswamy N, Joseph F, Goenka N. The Role Of Omega-3 Fatty Acids in Cardiovascular Disease, Hypertriglyceridaemia and Diabetes Mellitus. The British Journal of Diabetes & Vascular Disease. 2008 May;8(3):121-6

Davies M et al.: AT.LANTUS Study Group. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes Obesity and Metabolism. 2008 May;10(5):387-99

Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP and Fraser WD. The Circadian Rhythm of Osteoprotegerin and its Association with Parathyroid Hormone Secretion. Journal of Clinical Endocrinology and Metabolism. 2007 Aug;92(8):3230-8.

Durham BH, Joseph F, Bailey L, Fraser WD. The association of circulating ferritin with serum concentration of FGF-23 measured by three commercial assays. The Annals of Clinical Biochemistry. 2007 Sep;44(Pt 5):463-6.

Joseph F, Reeve-Fowkes A, Ewins D, Worth R, Goenka N. That looks as if it must have hurt-but did it? Painless spontaneous fracture of the os calcis in a type 2 diabetes patient. Practical Diabetes. 2007 Sep;24(7): 362.

Joseph F,  Younis N,  Sowery J,   Soran H,  Stanaway S, Bowen-Jones D. 2003 Blood pressure control in diabetes mellitus: are we achieving the guideline targets? Practical Diabetes 20(8): 276-282.

Joseph F, Owens V, Weir P, Little V, Barrett JA. 2003 Intracerebral haemorrhage masquerading as a transient ischaemic attack (TIA) in a patient with atrial fibrillation. CME in Geriatric Medicine 5(3): 93-132.

Joseph F, Younis N, Bowen-Jones D. 2003Treatment of carbimazole induced agranulocytosis and sepsis with granulocyte colony stimulating factor (G-CSF).  International Journal of Clinical Practice. 2003 Mar;57(2):145-6.

Soran H, Younis N,  Joseph F, Hayat Z, Zakhour H, Scott, A. A case of hemangiopericytoma- associated hypoglycaemia: beneficial effect of treatment with radiotherapy. International Journal of Clinical Practice.  2006 Oct;60(10):1319-1322.

Joseph F, N Younis, G Haydon,  DH Adams, S Wynne,  MB Gillet, YM Maurice,  ME Lipton,  D Berstock, IR Jones. Peliosis of the spleen with massive recurrent haemorrhagic ascites despite splenectomy associated with elevated vascular endothelial growth factor (VEGF) levels. European Journal of Gastroenterology and Hepatology. 2004 Nov;16(12):1401-6.

SG Williams, JH Silas, F Joseph,M Jackson, D Rittoo, P Currie. Troponin T: How high is high? relationship and differences between serum cardiac markers according to level of creatinine kinase and type of myocardial infarction. Post-graduate Medical Journal, 2004 Oct; 80:613-614.

Soran H, Vora J, Younis N, Joseph F, Campbell F, English P, Neoptolemus JP, Jones IR. A Multiple Endocrine Neoplasia Type 1 (MEN 1) caused by a new genetic mutation. The Endocrinologist. 2004 May;14(3):129-130.